Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$174,087,302
+$16,712,256 QoQ
Shares Held
1,354,765
+3.6% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#151
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Dec 31, 2020CallValue
$42,899
CallShares
1,048
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Creative Planning holds $1,825,978,859 across 16 Drug Manufacturers - General names. MRK ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
445,706 | $534,593,191 | |
| 2 | JNJ |
Johnson & Johnson
|
1,384,963 | $351,739,052 | |
| 3 | ABBV |
AbbVie Inc.
|
1,126,243 | $283,407,788 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
1,354,765 | $174,087,302 | |
| 5 | AMGN |
Amgen Inc
|
258,171 | $93,488,882 | |
| 6 | NVS |
Novartis AG
|
546,659 | $85,672,398 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
414,367 | $52,351,126 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
887,032 | $51,110,783 |
All Filings in MRK
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,087,302 | 1,354,765 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $157,375,046 | 1,308,297 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $131,222,483 | 1,246,651 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $90,351,316 | 1,076,508 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $74,778,572 | 944,651 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $89,598,162 | 998,197 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $91,693,003 | 921,723 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $95,671,119 | 842,472 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $107,359,716 | 867,203 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $109,061,293 | 826,535 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $85,806,479 | 787,071 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $91,958,954 | 893,239 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $80,735,498 | 699,675 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $72,507,869 | 681,529 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $74,701,303 | 673,288 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $58,409,512 | 678,234 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $63,077,423 | 691,866 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $53,735,283 | 654,909 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $35,108,477 | 458,096 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $36,026,286 | 479,647 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $33,416,212 | 429,680 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $34,076,342 | 442,033 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $42,899 | 1,000 | Call | Sole | 2021-01-29 | |
| 2020-12-31 | $36,427,405 | 445,323 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $41,475 | 500 | Call | Sole | 2020-11-05 | |
| 2020-09-30 | $35,308,264 | 425,657 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $31,119,693 | 402,427 | Shares | Sole | 2020-07-23 | |
| 2020-06-30 | $65,864 | 1,200 | Call | Sole | 2020-07-23 | |
| 2020-03-31 | $29,545,486 | 384,007 | Shares | Sole | 2020-05-05 | |
| 2020-03-31 | $38,469 | 500 | Call | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||